(Q83230378)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Jackson-Fisher AJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Bellinger G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Shum E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Duong JK

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Perkins AS

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Muller W

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kent Lloyd KC

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stern DF

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

number of pages

9

1 reference

inferred from page(s)

published in

Oncogene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

5664-5672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16652155%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209574

20 January 2020

exact match

0 references

cites work

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Prognostic value of ERBB family mRNA expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

c-erbB-4/HER4: friend or foe?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

c-erbB-4 protein expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Somatic mutations of the ERBB4 kinase domain in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Lung cancer: intragenic ERBB2 kinase mutations in tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Targeted therapy with imatinib: hits and misses?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021

Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209574

7 January 2021